Czech Pharmaco-epidemiological Study on Disease Modifying Drugs
Condition: Multiple Sclerosis Intervention: Drug: interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab Sponsor: IMPULS Endowment Fund Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Copaxone | Czechia Health | Epidemiology | Gilenya | Research | Rituxan | Study | Tysabri